CEDRIC: Clopidogrel- Effects on Diameter Reduction and Intimal Hyperplasia in Long-term Follow up after Cardiac Transplantation.

Trial Profile

CEDRIC: Clopidogrel- Effects on Diameter Reduction and Intimal Hyperplasia in Long-term Follow up after Cardiac Transplantation.

Completed
Phase of Trial: Phase II/III

Latest Information Update: 17 Nov 2015

At a glance

  • Drugs Clopidogrel (Primary)
  • Indications Cardiovascular disorders; Embolism and thrombosis; Heart transplant rejection
  • Focus Pharmacodynamics; Pharmacogenomic
  • Acronyms CEDRIC
  • Most Recent Events

    • 14 Nov 2015 Status changed from discontinued to completed as per European Clinical Trials Database record.
    • 07 Nov 2015 Status changed from recruiting to discontinued as reported by European Clinical Trials Database record.
    • 11 Oct 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top